Hyperdiploidy Is a Common Finding in Monoclonal Gammopathy of Undetermined Significance and Monosomy 13 Is Restricted to These Hyperdiploid Patients
暂无分享,去创建一个
X. Leleu | T. Facon | F. Geneviève | M. Zandecki | J. Gerard | A. Godon | T. Gastinne | M. Brousseau | J. Lai | M. Dib
[1] P. Loehrer,et al. International Staging System for Multiple Myeloma , 2006 .
[2] G. Ahmann,et al. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS. , 2005, Blood.
[3] P. L. Bergsagel,et al. Molecular pathogenesis and a consequent classification of multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Crowley,et al. International staging system for multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] F. Magrangeas,et al. Genetic heterogeneity in multiple myeloma , 2005, Leukemia.
[6] F. Magrangeas,et al. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma , 2005, Leukemia.
[7] U. Jäger,et al. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma , 2004, Leukemia.
[8] M. Höglund,et al. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation , 2004, British journal of haematology.
[9] P. L. Bergsagel,et al. Advances in biology of multiple myeloma: clinical applications. , 2004, Blood.
[10] Bart Barlogie,et al. Genetics and Cytogenetics of Multiple Myeloma , 2004, Cancer Research.
[11] Gonzalez,et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. , 2003, Blood.
[12] M. Rue,et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. , 2003, Blood.
[13] Kenneth C. Anderson,et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group , 2003, British journal of haematology.
[14] Martins Marta,et al. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia , 2003, Cancer.
[15] R. Fonseca,et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma , 2003, Leukemia.
[16] A. Órfão,et al. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. , 2003, Cancer.
[17] R. Bataille,et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. , 2002, Blood.
[18] G. Ahmann,et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. , 2002, Blood.
[19] R. Bataille,et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. , 2002, Blood.
[20] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[21] C. Bastard,et al. Hypodiploidy is a major prognostic factor in multiple myeloma. , 2001, Blood.
[22] U. Jäger,et al. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance , 2000, Leukemia.
[23] B. Barlogie,et al. Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. , 2000, Blood.
[24] H. Kaufmann,et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. , 2000, Blood.
[25] R. Bataille,et al. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myélome. , 1999, Blood.
[26] R. Bataille,et al. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. , 1999, Cancer research.
[27] G. Ehninger,et al. The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease. , 1998, American journal of clinical pathology.
[28] F. Bauters,et al. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. , 1997, Blood.
[29] B. Barlogie,et al. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Cigudosa,et al. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations , 1997, Genes, chromosomes & cancer.
[31] T. Facon,et al. MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMAL , 1996, British journal of haematology.
[32] O. Haas,et al. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. , 1995, Blood.
[33] T. Facon,et al. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells , 1995, British journal of haematology.
[34] J. Miguel,et al. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients , 1995, British journal of haematology.
[35] J. Mary,et al. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. , 1995, Blood.
[36] F. Bauters,et al. Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study. , 1994, Cancer genetics and cytogenetics.
[37] A. Tienhaara,et al. Flow cytometric DNA analysis and clinical correlations in multiple myeloma. , 1992, American journal of clinical pathology.
[38] J. Drach,et al. The biological and clinical significance of the KI‐67 growth fraction in multiple myeloma , 1992, Hematological oncology.
[39] G. Mazzini,et al. Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study. , 1990, British Journal of Cancer.
[40] B. Barlogie,et al. Ploidy and proliferative characteristics in monoclonal gammopathies. , 1982, Blood.